NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

雙特異性單株抗體的全球市場(2021年):COVID-19造成的成長與至2030年的變化

Bi-Specific MAbS Global Market Report 2021: COVID 19 Growth And Change to 2030

出版商 The Business Research Company 商品編碼 1009559
出版日期 按訂單生產 內容資訊 英文 175 Pages
商品交期: 2-10個工作天內
價格
雙特異性單株抗體的全球市場(2021年):COVID-19造成的成長與至2030年的變化 Bi-Specific MAbS Global Market Report 2021: COVID 19 Growth And Change to 2030
出版日期: 按訂單生產內容資訊: 英文 175 Pages
簡介

本報告提供全球雙特異性單株抗體市場的相關調查,市場規模和預測,成長及阻礙因素,競爭情形,市場佔有率,市場趨勢與策略,各類型、產品類型、適應症、地區/國家的市場分析,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 雙特異性單株抗體市場特徵

第3章 雙特異性單株抗體的市場趨勢與策略

第4章 COVID-19對雙特異性單株抗體的影響

第5章 雙特異性單株抗體的市場規模與成長

  • 全球雙特異性單株抗體市場成果(2015-2020)
    • 市場成長要素
    • 市場阻礙因素
  • 全球雙特異性單株抗體市場預測(2020-2025F,2030F)
    • 市場成長要素
    • 市場阻礙因素

第6章 雙特異性單株抗體市場區隔

  • 全球市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • Catumaxomab (Removab)
  • Blinatumomab
  • Duligotumab
  • SAR 156597
  • 全球市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • In Vivo
  • In Vitro
  • 全球市場:各適應症市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 癌症
  • 自體免疫疾病
  • 發炎性疾病
  • 感染疾病
  • 微生物病
  • 其他
  • 全球市場:各最終用途市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 醫院
  • 研究機關

第7章 雙特異性單株抗體市場地區以及各國分析

  • 全球市場:各地區,成果及預測(2015-2020,2020-2025F,2030F)
  • 全球市場:各國,成果及預測(2015-2020,2020-2025F,2030F)

第8章 亞太地區的雙特異性單株抗體市場

  • 亞太地區的市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府舉措,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 亞太地區市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第9章 中國的雙特異性單株抗體市場

  • 中國的市場概要
  • 中國市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 中國市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第10章 印度的雙特異性單株抗體市場

  • 印度市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 印度市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第11章 日本的雙特異性單株抗體市場

  • 日本市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 日本市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第12章 澳洲的雙特異性單株抗體市場

  • 澳洲市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 澳洲市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第13章 印尼的雙特異性單株抗體市場

  • 印尼市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 印尼市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第14章 韓國的雙特異性單株抗體市場

  • 韓國市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 韓國市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第15章 西歐的雙特異性單株抗體市場

  • 西歐的市場概要
  • 西歐市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 西歐市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第16章 英國的雙特異性單株抗體市場

  • 英國市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 英國市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第17章 德國的雙特異性單株抗體市場

  • 德國市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 德國市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第18章 法國的雙特異性單株抗體市場

  • 法國市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 法國市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第19章 東歐的雙特異性單株抗體市場

  • 東歐的市場概要
  • 東歐市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 東歐市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第20章 俄羅斯的雙特異性單株抗體市場

  • 俄羅斯市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 俄羅斯市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第21章 北美的雙特異性單株抗體市場

  • 北美的市場概要
  • 北美市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 北美市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第22章 美國的雙特異性單株抗體市場

  • 美國的市場概要
  • 美國市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 美國市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第23章 南美的雙特異性單株抗體市場

  • 南美的市場概要
  • 南美市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 南美市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第24章 巴西的雙特異性單株抗體市場

  • 巴西市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 巴西市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第25章 中東的雙特異性單株抗體市場

  • 中東的市場概要
  • 中東市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 中東市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第26章 非洲的雙特異性單株抗體市場

  • 非洲的市場概要
  • 非洲市場:各類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)
  • 非洲市場:各產品類型市場區隔,成果及預測(2015-2020,2020-2025F,2030F)

第27章 雙特異性單株抗體市場競爭情形和企業簡介概要

  • 雙特異性單株抗體市場競爭情形
  • 雙特異性單株抗體市場企業簡介概要
    • Johnson & Johnson
    • Novartis AG
    • Hoffmann-La Roche Ltd.
    • Novo Nordisk A/S
    • Bayer AG

第28章 雙特異性單株抗體開發平台分析

第29章 雙特異性單株抗體市場上主要合併和收購

第30章 雙特異性單株抗體市場未來展望和潛力分析

第31章 附錄

目錄

Bi-Specific MAbS Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global bi-specific mabs market.

This report focuses on bi-specific mabs market which is experiencing strong growth. The report gives a guide to the bi-specific mabs market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the bi-specific mabs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Bi-Specific MAbS market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider bi-specific mabs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The bi-specific mabs market section of the report gives context. It compares the bi-specific mabs market with other segments of the bi-specific mabs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, bi-specific mabs indicators comparison.

Scope

Markets Covered: 1) By Type: Catumaxomab (Removab); Blinatumomab; Duligotumab; SAR 156597

2) By Product Type: In Vivo; In Vitro

3) By Indication: Cancer; Autoimmune Diseases; Inflammatory Diseases; Infectious Diseases; Microbial Diseases; Others

4) By End Use: Hospitals; Research Institutes; Other

Companies Mentioned: Johnson & Johnson; Novartis AG; Hoffmann-La Roche Ltd.; Novo Nordisk A/S; Bayer AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Bi-Specific MAbS Market Characteristics

3. Bi-Specific MAbS Market Trends And Strategies

4. Impact Of COVID-19 On Bi-Specific MAbS

5. Bi-Specific MAbS Market Size And Growth

  • 5.1. Global Bi-Specific MAbS Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Bi-Specific MAbS Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Bi-Specific MAbS Market Segmentation

  • 6.1. Global Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Catumaxomab (Removab)
  • Blinatumomab
  • Duligotumab
  • SAR 156597
  • 6.2. Global Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • In Vivo
  • In Vitro
  • 6.3. Global Bi-Specific MAbS Market, Segmentation By Indication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer
  • Autoimmune Diseases
  • Inflammatory Diseases
  • Infectious Diseases
  • Microbial Diseases
  • Others
  • 6.4. Global Bi-Specific MAbS Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Research Institutes

7. Bi-Specific MAbS Market Regional And Country Analysis

  • 7.1. Global Bi-Specific MAbS Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Bi-Specific MAbS Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Bi-Specific MAbS Market

  • 8.1. Asia-Pacific Bi-Specific MAbS Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Bi-Specific MAbS Market

  • 9.1. China Bi-Specific MAbS Market Overview
  • 9.2. China Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Bi-Specific MAbS Market

  • 10.1. India Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Bi-Specific MAbS Market

  • 11.1. Japan Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Bi-Specific MAbS Market

  • 12.1. Australia Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Bi-Specific MAbS Market

  • 13.1. Indonesia Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Bi-Specific MAbS Market

  • 14.1. South Korea Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Bi-Specific MAbS Market

  • 15.1. Western Europe Bi-Specific MAbS Market Overview
  • 15.2. Western Europe Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Bi-Specific MAbS Market

  • 16.1. UK Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Bi-Specific MAbS Market

  • 17.1. Germany Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Bi-Specific MAbS Market

  • 18.4. France Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Bi-Specific MAbS Market

  • 19.1. Eastern Europe Bi-Specific MAbS Market Overview
  • 19.2. Eastern Europe Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Bi-Specific MAbS Market

  • 20.1. Russia Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Bi-Specific MAbS Market

  • 21.1. North America Bi-Specific MAbS Market Overview
  • 21.2. North America Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Bi-Specific MAbS Market

  • 22.1. USA Bi-Specific MAbS Market Overview
  • 22.2. USA Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Bi-Specific MAbS Market

  • 23.1. South America Bi-Specific MAbS Market Overview
  • 23.2. South America Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Bi-Specific MAbS Market

  • 24.1. Brazil Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Bi-Specific MAbS Market

  • 25.1. Middle East Bi-Specific MAbS Market Overview
  • 25.2. Middle East Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Bi-Specific MAbS Market

  • 26.1. Africa Bi-Specific MAbS Market Overview
  • 26.2. Africa Bi-Specific MAbS Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Bi-Specific MAbS Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Bi-Specific MAbS Market Competitive Landscape And Company Profiles

  • 27.1. Bi-Specific MAbS Market Competitive Landscape
  • 27.2. Bi-Specific MAbS Market Company Profiles
    • 27.2.1. Johnson & Johnson
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Hoffmann-La Roche Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Novo Nordisk A/S
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Bayer AG
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Bi-Specific MAbS Pipeline Analysis

29. Key Mergers And Acquisitions In The Bi-Specific MAbS Market

30. Bi-Specific MAbS Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer